How Much Does Crestor (Rosuvastatin) Cost in Wisconsin in 2026?

Brand vs. Generic Pricing in Wisconsin

The gap between brand Crestor and generic rosuvastatin is wide enough to change a patient's monthly budget. AstraZeneca's branded Crestor carries a list price near $290 per month in 2026. Generic rosuvastatin, available from multiple manufacturers since patent expiration in 2016, averages roughly $15 per month across Wisconsin retail pharmacies.

That $275 difference matters. For a patient on a fixed income filling 12 prescriptions per year, the annual savings from choosing generic rosuvastatin over brand Crestor exceed $3,300. Wisconsin pharmacists may substitute the generic automatically under state substitution law unless the prescriber writes "brand medically necessary" on the prescription. The FDA considers generic rosuvastatin bioequivalent to Crestor, meaning the clinical effect is the same at equivalent doses.

Prices do vary by pharmacy. A Walgreens in Milwaukee may charge differently than an independent pharmacy in Eau Claire. Patients without insurance should compare prices at two or three pharmacies before filling. GoodRx-type discount platforms sometimes push generic rosuvastatin below $10 per month at select Wisconsin locations, though those prices fluctuate weekly.

Rosuvastatin earned its reputation in the JUPITER trial (N=17,802), which demonstrated a 44% reduction in the primary cardiovascular endpoint among patients with elevated high-sensitivity C-reactive protein but LDL cholesterol below 130 mg/dL. That trial reshaped how clinicians think about statin therapy for primary prevention, and it used the 20 mg dose specifically [1].

Wisconsin Medicaid Coverage for Rosuvastatin

Wisconsin Medicaid does cover rosuvastatin, but requires prior authorization. This is not a denial. It is a documentation step.

The PA process typically requires the prescriber to show that the patient has a qualifying diagnosis (hyperlipidemia, atherosclerotic cardiovascular disease risk, or a related condition) and that the chosen dose is clinically appropriate. For most patients with a documented lipid panel and a clear indication, approval takes one to five business days. Some providers report same-day electronic PA approval through the Wisconsin ForwardHealth portal.

Wisconsin Medicaid preferred drug lists tend to favor generic statins over branded options. Because generic rosuvastatin is inexpensive, the PA barrier is relatively low compared to newer lipid-lowering agents like PCSK9 inhibitors, which face stricter utilization management. The 2018 AHA/ACC Cholesterol Guideline classifies rosuvastatin 20 to 40 mg as high-intensity statin therapy, the recommended tier for patients with clinical ASCVD or LDL cholesterol of 190 mg/dL or above [2].

Patients enrolled in Wisconsin BadgerCare Plus (the state's Medicaid expansion program) follow the same ForwardHealth formulary. If a PA is denied, patients have the right to appeal through the Wisconsin Department of Health Services. The prescriber can also request an expedited review if the medication is clinically urgent.

One practical tip: ask the prescribing clinic to submit the PA before sending the prescription to the pharmacy. This avoids the frustrating scenario where a patient arrives at the pharmacy counter only to learn the claim was rejected pending authorization.

Compounded Rosuvastatin in Wisconsin: Legal and Available

Compounded rosuvastatin is legal in Wisconsin when dispensed by a licensed 503A compounding pharmacy. This route can bring out-of-pocket costs close to zero for some patients.

Under federal law, 503A pharmacies operate under Section 503A of the Federal Food, Drug, and Cosmetic Act. They compound medications based on individual patient prescriptions, provided they follow state pharmacy board regulations and do not produce large-scale batches for general distribution. Wisconsin's Pharmacy Examining Board recognizes 503A compounding as a lawful pharmacy practice.

Why would a patient choose compounded rosuvastatin? A few reasons. Some patients cannot swallow standard tablets and need a liquid suspension. Others have allergies to inactive ingredients (fillers, dyes, or lactose) present in commercial tablets. Compounding pharmacies can formulate rosuvastatin without those excipients. Cost can also be a factor: certain telehealth platforms partner with 503A pharmacies to offer rosuvastatin at no additional charge beyond a membership or consultation fee.

The FDA distinguishes 503A pharmacies (patient-specific prescriptions) from 503B outsourcing facilities (which can produce larger quantities without individual prescriptions). Both operate in Wisconsin, but 503A is the more common pathway for individual statin prescriptions. Patients should verify that any compounding pharmacy they use holds a current Wisconsin pharmacy license and complies with USP <795> standards for non-sterile compounding [3].

Insurance Coverage Beyond Medicaid

Most commercial insurance plans in Wisconsin place generic rosuvastatin on Tier 1 or Tier 2 of their formularies. Brand Crestor, when covered at all, typically sits on Tier 3 or higher.

What this means in dollars: a Tier 1 generic copay in Wisconsin usually ranges from $0 to $15 per 30-day supply. A Tier 3 brand copay can run $40 to $75 or more, depending on the plan. For patients on high-deductible health plans, the full retail price applies until the deductible is met, making the $15 generic price especially relevant early in the calendar year.

The major insurers operating in Wisconsin (including Anthem Blue Cross Blue Shield, Quartz, Group Health Cooperative of South Central Wisconsin, and Dean Health Plan) all list generic rosuvastatin as a preferred statin on their 2026 formularies. According to the American College of Cardiology's 2018 guideline on blood cholesterol management, high-intensity statin therapy is recommended for adults aged 40 to 75 with LDL cholesterol at or above 190 mg/dL, those with diabetes, or those with a 10-year ASCVD risk of 7.5% or higher [2].

Medicare Part D plans in Wisconsin also cover generic rosuvastatin. Under the Inflation Reduction Act provisions taking effect through 2025 and 2026, Medicare beneficiaries benefit from the $2,000 annual out-of-pocket prescription drug cap. For a patient whose only medication is generic rosuvastatin, this cap is unlikely to come into play given the low monthly cost. But for patients on multiple medications, the cap provides meaningful protection.

Employer-sponsored plans vary more. Patients should check their specific formulary or call the number on the back of their insurance card. Pharmacy benefit managers (PBMs) like Express Scripts, CVS Caremark, and OptumRx negotiate different rates, so two Wisconsin residents with different employers may pay different amounts for the same generic tablet.

Discount Programs and Savings Cards

Several pathways exist to reduce rosuvastatin costs in Wisconsin below standard retail pricing. None of them require insurance.

AstraZeneca historically offered a Crestor savings card for commercially insured patients. With generic rosuvastatin widely available and priced at approximately $15 per month, brand savings cards have become less relevant for most patients. However, AstraZeneca's program may still benefit the small number of patients whose physicians specify brand-only Crestor. Eligibility typically excludes government-insured patients (Medicare, Medicaid, Tricare).

For generic rosuvastatin, the most practical discount tools in Wisconsin include pharmacy discount cards from platforms like GoodRx, RxSaver, and SingleCare. These are free to use and accepted at most chain pharmacies (Walgreens, CVS, Walmart, Costco) and many independents statewide. Prices through these platforms for a 30-day supply of generic rosuvastatin 10 mg or 20 mg commonly fall between $8 and $18 at Wisconsin pharmacies as of mid-2026.

Walmart and Costco pharmacies in Wisconsin have historically offered rosuvastatin on their respective discount generic lists, sometimes at $4 to $10 per month for common doses. Costco's pharmacy is accessible to non-members in Wisconsin under state law, which can be a useful option for uninsured patients near a Costco location.

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) is another option. It operates as a mail-order pharmacy and ships to Wisconsin addresses. Their pricing model adds a flat markup plus a dispensing fee to the manufacturer's cost, often resulting in prices below $10 per month for generic rosuvastatin.

The Wisconsin Department of Health Services also maintains a list of pharmaceutical assistance programs through its SeniorCare program, which serves Wisconsin residents aged 65 and older with incomes at or below 240% of the federal poverty level. SeniorCare covers generic statins with low copayments [4].

Telehealth Prescribing of Rosuvastatin in Wisconsin

Wisconsin permits telehealth prescribing of rosuvastatin. No in-person visit is required for a statin prescription.

The Wisconsin Medical Examining Board recognizes synchronous audio-video telemedicine encounters as valid for establishing a prescriber-patient relationship, which is the legal prerequisite for issuing a prescription. Rosuvastatin is not a controlled substance and carries no additional telehealth prescribing restrictions beyond those that apply to any prescription medication.

Several national telehealth platforms serve Wisconsin patients for cardiovascular risk management, including statin prescriptions. Some of these platforms bundle the consultation fee with medication fulfillment through a partner 503A pharmacy, creating a single monthly charge that includes both the provider visit and the medication. For patients who prefer this model, the effective cost of rosuvastatin can drop to zero beyond the platform subscription.

A standard telehealth rosuvastatin visit in Wisconsin typically includes a review of recent lab work (lipid panel, liver function tests), assessment of cardiovascular risk factors, and a discussion of statin intensity. The 2018 ACC/AHA guideline recommends checking a fasting lipid panel before initiating therapy and repeating it 4 to 12 weeks after starting or adjusting the dose [2].

Patients without recent labs can often order them through the telehealth platform or visit a local Quest Diagnostics or Labcorp draw site in Wisconsin. Most Wisconsin locations of both lab companies accept walk-in appointments for provider-ordered lipid panels.

Rosuvastatin Dosing and Clinical Context

Rosuvastatin is dosed once daily, with or without food, at strengths of 5, 10, 20, or 40 mg. The starting dose for most adults is 10 to 20 mg. The 40 mg dose is reserved for patients who do not reach their LDL goal on 20 mg.

The drug's potency sets it apart from other statins. Rosuvastatin 10 mg lowers LDL cholesterol by approximately 46%, while atorvastatin requires 20 mg to achieve a comparable reduction. At its maximum 40 mg dose, rosuvastatin reduces LDL by roughly 55% [5]. The JUPITER trial demonstrated that rosuvastatin 20 mg reduced LDL cholesterol by 50% from a median baseline of 108 mg/dL and lowered high-sensitivity CRP by 37% [1].

"For patients who need aggressive LDL lowering, rosuvastatin remains one of the most potent oral options available," notes the Endocrine Society's clinical practice guideline on lipid management [6]. The guideline emphasizes that statin intensity should match cardiovascular risk, not simply LDL level.

Side effects are consistent with the statin class: myalgia in roughly 5 to 10% of patients, elevated liver enzymes (rare, typically reversible), and a small increase in the risk of new-onset type 2 diabetes. The JUPITER trial reported a 27% relative increase in physician-reported diabetes among rosuvastatin-treated patients compared to placebo, translating to about 1 additional case per 167 patients treated over 1.9 years [1]. For most patients at moderate to high ASCVD risk, the cardiovascular benefit substantially outweighs this risk.

Wisconsin clinicians typically order a baseline hepatic panel and repeat it once after initiation. Routine monitoring of creatine kinase is not recommended unless the patient reports muscle symptoms.

How Wisconsin Compares to Neighboring States

Generic rosuvastatin pricing in Wisconsin is broadly similar to that in Minnesota, Iowa, Illinois, and Michigan. All five states allow generic substitution by default, and all have competitive retail pharmacy markets that keep generic statin prices low.

Wisconsin Medicaid's PA requirement for rosuvastatin is slightly more restrictive than Illinois Medicaid, which lists generic rosuvastatin as preferred without PA for most patients. Minnesota's Medical Assistance program also covers rosuvastatin but applies step-therapy requirements in some managed care plans. Michigan Medicaid covers rosuvastatin with PA similar to Wisconsin.

For compounded rosuvastatin, Wisconsin's regulatory environment is permissive compared to some states. The Wisconsin Pharmacy Examining Board does not impose additional state-level restrictions beyond federal 503A requirements, making compounded rosuvastatin relatively accessible across the state.

Patients living near the Wisconsin-Illinois or Wisconsin-Minnesota border may find marginally different cash prices by shopping across state lines. Pharmacy discount card prices vary by pharmacy location, not by state of residence, so a Wisconsin resident can legally fill a prescription at a Minnesota pharmacy if the price is lower.

Who Should Consider Rosuvastatin Over Other Statins

Not every patient needs rosuvastatin specifically. But certain clinical scenarios favor it.

Patients requiring high-intensity therapy (greater than 50% LDL reduction) have two first-line options: rosuvastatin 20 to 40 mg or atorvastatin 40 to 80 mg. The choice often comes down to tolerability, drug interactions, and cost. Rosuvastatin has fewer cytochrome P450 interactions than atorvastatin because it is metabolized primarily through CYP2C9 rather than CYP3A4 [5]. Patients taking medications like diltiazem, amiodarone, or certain HIV protease inhibitors may tolerate rosuvastatin more safely.

For patients with chronic kidney disease (estimated GFR 30 to 60 mL/min), rosuvastatin 5 to 10 mg is often preferred. The 40 mg dose is contraindicated in severe renal impairment per the FDA label [5]. Atorvastatin does not require renal dose adjustment, making it the better option for patients with eGFR below 30.

Rosuvastatin also produces slightly larger increases in HDL cholesterol compared to atorvastatin at equipotent doses, though the clinical significance of statin-mediated HDL changes remains debated. The VOYAGER meta-analysis (N=32,258) found rosuvastatin raised HDL by 7.7% at 10 mg vs. 4.4% for atorvastatin 20 mg [7].

At Wisconsin's current generic pricing, cost is not a major differentiator between rosuvastatin and atorvastatin. Both generics average $10 to $20 per month at retail pharmacies statewide. The prescribing decision should be based on clinical factors, not price.